The trademark application GAMROZYNE was filed by BIMEDA ANIMAL HEALTH LIMITED, a corporation established under the laws of Ireland (the "Applicant"). The application was published for oppositions on May 29, 2023, and it was registered by office on September 5, 2023 without any oppositions.
It was designated 'Basic Application' for International Application 1750243 at the World Intellectual Property Organization (WIPO).
The application was filed in English (French was selected as the second language).